Statement
This report is prepared by the bond custodian, Caitong Securities Co., Ltd., in accordance with the "Administrative Measures for the Issuance and Trading of Corporate Bonds," "Code of Professional Conduct for Bond Custodians," the "Custody Management Agreement between Guangdong Baolite Medical Technology Co., Ltd. and Caitong Securities Co., Ltd. for the Issuance of Convertible Corporate Bonds by Guangdong Baolite Medical Technology Co., Ltd. to Unspecified Targets in 2020" (hereinafter referred to as the "Custody Management Agreement"), the "Prospectus for the Issuance of Convertible Corporate Bonds by Guangdong Baolite Medical Technology Co., Ltd. on the ChiNext Market to Unspecified Targets" (hereinafter referred to as the "Prospectus"), and other publicly disclosed information, as well as relevant announcements and explanatory documents issued by Guangdong Baolite Medical Technology Co., Ltd. (hereinafter referred to as the "Company").
This report does not constitute a recommendation for investors to take or not take any action. Investors should make independent judgments on relevant matters and should not treat any content in this report as a commitment or statement by Caitong Securities.
I. Approval Status of This Convertible Bond Issuance
With the approval of the China Securities Regulatory Commission's "Document No. Zhengjian Xuke [2020] 1831," the Company issued 2.19 million convertible corporate bonds to unspecified targets on September 4, 2020. Each bond has a face value of 100 yuan, with a total issuance amount of 219 million yuan. After deducting all issuance expenses (excluding tax), the net proceeds raised were 212.6775 million yuan. These funds were fully received on September 10, 2020, and audited by Dahua Certified Public Accountants (Special General Partnership) in their "Capital Verification Report No. Dahua Yanzhi (2020) 000539."
II. Basic Information of This Convertible Bond Issuance
(I) Bond Abbreviation and Code: Baolite Convertible Bond, 123065.
(II) Issuance Date: September 4, 2020.
(III) Issuance Size: 219 million yuan.
(IV) Bond Term: 6 years.
(V) Bond Interest Rate: 0.4% for the first year, 0.7% for the second year, 1.0% for the third year, 1.8% for the fourth year, 2.5% for the fifth year, and 3.5% for the sixth year.
(VI) Principal Repayment and Interest Payment Period and Method
The convertible corporate bonds issued will pay interest once a year. Upon maturity, the principal of all outstanding convertible corporate bonds that have not been converted will be repaid along with the interest for the final year.
- Calculation of Annual Interest
Annual interest refers to the current interest that holders of convertible corporate bonds can receive for every full year from the issuance date of these convertible corporate bonds, based on the total face value of the convertible corporate bonds they hold.
The formula for calculating annual interest is: I = B × i
I: Annual interest amount.
B: The total face value of convertible corporate bonds held by the holder of convertible corporate bonds on the record date for interest payment in the interest calculation year (hereinafter referred to as "current year" or "each year").
i: The annual face interest rate of this convertible corporate bond for the current year.
- Interest Payment Method